Image credit: Nushin Rashidian

House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling 

The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.

Regulation
Regulation

Pres. Biden Formally Announces DOJ Will Move to Reclassify Cannabis

Now, the public will have a chance to weigh in on cannabis rescheduling.